Shares of HeartWare International gain after the medical device company reports positive results for a post-approval study of its HVAD implantable heart pump.
HeartWare International (NSDQ:HTWR) shares are up today on the medical device company's 1st release of data since its HVAD implantable heart pump went on the U.S. market.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1iicPzo
Cap comentari:
Publica un comentari a l'entrada